Persist AI Teams up with Microsize and Micromacinazione (Micmac) to Launch First-of-Its-Kind Early-Stage "Micromill" Formulation Platform, Enabling Drug Development Decision ...

Persist AI, an AI and robotics-powered pharmaceutical formulation research company, today announced a strategic collaboration with Microsize and Micromacinazione, pioneers in pharmaceutical ...
GEN

Machine Learning Accelerates Drug Formulation

Researchers at the University of Toronto say they have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine ...
MarketWatch

Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A Funding

The MarketWatch News Department was not involved in the creation of this content. AI-driven robotics platform reduces drug formulation development time from years to months SACRAMENTO, Calif., May 19, ...
PharmTech

Pharma Fundamentals: Utilizing Artificial Intelligence in Drug Development

Artificial intelligence is shifting formulation development from empirical trial-and-error to predictive, data-driven design ...
MarketWatch

CyanoCapture and Persist AI Announce Strategic Collaboration to Build World's First Robotic GMP Facility for Oral Protein and Peptide Drugs

SAN FRANCISCO, Feb. 18, 2026 /PRNewswire/ -- CyanoCapture, the innovator in cyanobacteriabased oral drug delivery, and Persist AI, the leader in AI-driven robotic pharmaceutical formulation, today ...
Science Daily

Scientists use machine learning to fast-track drug formulation development

Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...
PharmTech

Overcoming Formulation Challenges for Biosimilars

High-concentration formulations and patient centricity are challenges to the formulation of biosimilars, which already face patent protection barriers. Biosimilar formulation development requires ...

Quotient Sciences Advances AI-Designed Drug Product into Clinical Development

Quotient Sciences today announces the successful initiation of a clinical study evaluating a novel drug product developed ...
News Medical

Navigating the complexities of controlled release drug formulations

This interview addresses the challenges and complexities of developing and manufacturing controlled-release drug formulations. Could you introduce yourself and your expertise in drug development and ...

Top Softgel Machine Manufacturer Advances Innovation in Global Pharmaceutical Equipment Industry

Yantai Boxin Pharmaceutical Machinery Co., Ltd., a recognized manufacturer of pharmaceutical processing and softgel production equipment, continues to strengthen its presence in the global healthcare ...
Business Wire

Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced that it has entered into an exclusive ...